PharmiWeb.com - Global Pharma News & Resources

Marketing - Press Releases

Date Title Company
22-Jul-2020 Novel Platforms in Ocular Drug Delivery workshop discussed at Ophthalmic Drugs SMi Ltd
21-Jul-2020 UCLB and Apollo Therapeutics secure first out-licensing deal to Deerfield, a leading U.S. healthcare investment firm UCLB
20-Jul-2020 Oxford Biomedica notes interim results from AstraZeneca on AZD1222 showing strong antibody and T-cell responses and acceptable safety profile Oxford Biomedica plc
20-Jul-2020 Tiziana Life Sciences plc Director Appointment Tiziana Life Sciences plc
20-Jul-2020 Synairgen announces positive results from trial of SNG001 in hospitalised COVID-19 patients Synairgen plc
20-Jul-2020 Phlexglobal and Arkivum join forces to enable Trial Master File data compliance over its entire extended lifecycle Arkivum
20-Jul-2020 Acumentice expands senior team with Purdy appointment Acumentice
20-Jul-2020 Annual Review 2020 highlights impact on growth and productivity in the UK cell and gene therapy industry Cell and Gene Therapy Catapult
20-Jul-2020 AMRYT TO ANNOUNCE Q2 RESULTS ON AUGUST 6, 2020 Amryt
20-Jul-2020 BERGENBIO ANNOUNCES FIRST PATIENT DOSED IN RECURRENT GLIOBLASTOMA INVESTIGATOR SPONSORED PHASE I/II STUDY ASSESSING SELECTIVE AXL INHIBITOR BEMCENTINIB BerGenBio ASA
20-Jul-2020 Santhera to Join SIX Swiss Exchange Life Science Industry Indices Santhera Pharmaceuticals
20-Jul-2020 Pfizer and BioNTech Announce Agreement with the United Kingdom for 30 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2 BioNTech
20-Jul-2020 Sanifit to start new clinical development program of SNF472 in End Stage Kidney Disease patients with Peripheral Artery Disease Sanifit
20-Jul-2020 PTC Therapeutics Announces Agreement to Monetize a Portion of the Risdiplam Royalty Stream for $650 Million PTC Therapeutics, Inc.
17-Jul-2020 Verona Pharma Raises $200 Million in Oversubscribed Private Placement and Subscription Verona Pharma plc
17-Jul-2020 RedHill Biopharma Receives Approval for Phase 2/3 COVID-19 Study in Russia RedHill Biopharma Ltd
17-Jul-2020 Celltrion launches human clinical trial of potential COVID-19 antiviral antibody treatment following positive pre-clinical results Celltrion Healthcare
17-Jul-2020 Eli Lilly’s and Regeneron’s COVID-19 mAbs spark interest as monotherapies along with potential as cocktails for treatment and postexposure prevention, says GlobalData GlobalData
17-Jul-2020 Tiziana Announces Submission of Patent Application on Use of Foralumab, the Only Fully Human Anti-CD3 Monoclonal Antibody, to Enhance Success of CAR-T Therapy Tiziana Life Sciences plc
17-Jul-2020 Tiziana Life Sciences plc Change to ADS Ratio - Updated Tiziana Life Sciences plc